7-nitroindazole has been researched along with Dyskinesia, Medication-Induced in 11 studies
7-nitroindazole: an inhibitor of nitric oxide synthase; exhibits anti-nociceptive activity without increasing blood pressure
Excerpt | Relevance | Reference |
---|---|---|
"Chronic L-DOPA pharmacotherapy in Parkinson's disease is often accompanied by the development of abnormal and excessive movements known as L-DOPA-induced dyskinesia." | 1.35 | Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease. ( Del-Bel, EA; Echeverry, MB; Padovan-Neto, FE; Tumas, V, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (18.18) | 29.6817 |
2010's | 8 (72.73) | 24.3611 |
2020's | 1 (9.09) | 2.80 |
Authors | Studies |
---|---|
Herrero, MT | 1 |
Yuste, JE | 1 |
Cuenca-Bermejo, L | 1 |
Almela, P | 1 |
Arenas-Betancur, L | 1 |
De Pablos, V | 1 |
Gonzalez-Cuello, A | 1 |
Del Bel, E | 3 |
Navarro-Zaragoza, J | 1 |
Fernández-Villalba, E | 1 |
Padovan-Neto, FE | 6 |
Ferreira, NR | 1 |
de Oliveira-Tavares, D | 1 |
de Aguiar, D | 1 |
da Silva, CA | 1 |
Raisman-Vozari, R | 3 |
Del-Bel, E | 3 |
Szawka, RE | 1 |
da-Silva, CA | 4 |
Anselmo-Franci, J | 2 |
Romano-Dutra, AC | 1 |
Guimaraes, FS | 1 |
Cavalcanti-Kiwiatkoviski, R | 1 |
Carolino, RO | 1 |
Solís, O | 1 |
Espadas, I | 1 |
Del-Bel, EA | 2 |
Moratalla, R | 1 |
Bortolanza, M | 2 |
Cavalcanti-Kiwiatkoski, R | 1 |
Mitkovski, M | 1 |
Bariotto-Dos-Santos, KD | 1 |
Dos-Santos-Pereira, M | 1 |
Echeverry, MB | 1 |
Tumas, V | 2 |
Novaretti, N | 1 |
Del Bel, EA | 1 |
Takuma, K | 1 |
Tanaka, T | 1 |
Takahashi, T | 1 |
Hiramatsu, N | 1 |
Ota, Y | 1 |
Ago, Y | 1 |
Matsuda, T | 1 |
Araki, T | 1 |
Mizutani, H | 1 |
Matsubara, M | 1 |
Imai, Y | 1 |
Mizugaki, M | 1 |
Itoyama, Y | 1 |
11 other studies available for 7-nitroindazole and Dyskinesia, Medication-Induced
Article | Year |
---|---|
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate.
Topics: Animals; Antiparkinson Agents; Dyskinesia, Drug-Induced; Levodopa; Parkinson Disease; Parkinsonian D | 2023 |
Anti-dyskinetic effect of the neuronal nitric oxide synthase inhibitor is linked to decrease of FosB/deltaFosB expression.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dyskinesia, Drug-Induced; Indazoles; Levodopa; Male; | 2013 |
Counteraction by nitric oxide synthase inhibitor of neurochemical alterations of dopaminergic system in 6-OHDA-lesioned rats under L-DOPA treatment.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Dopamine; Dyskinesia, Drug-Induced; Enzyme Inhibitor | 2014 |
Effects of prolonged neuronal nitric oxide synthase inhibition on the development and expression of L-DOPA-induced dyskinesia in 6-OHDA-lesioned rats.
Topics: Animals; Dyskinesia, Drug-Induced; Enzyme Inhibitors; Indazoles; Levodopa; Male; Nitric Oxide Syntha | 2015 |
Nitric oxide synthase inhibition decreases l-DOPA-induced dyskinesia and the expression of striatal molecular markers in Pitx3(-/-) aphakia mice.
Topics: Animals; Antiparkinson Agents; Benserazide; Cell Count; Corpus Striatum; Disease Models, Animal; Dop | 2015 |
Glial activation is associated with l-DOPA induced dyskinesia and blocked by a nitric oxide synthase inhibitor in a rat model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dyskinesia, Drug-Induced; Indazoles; Inflamma | 2015 |
Antidyskinetic Effect of 7-Nitroindazole and Sodium Nitroprusside Associated with Amantadine in a Rat Model of Parkinson's Disease.
Topics: Amantadine; Animals; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Dyskinesia, | 2016 |
Nitric oxide synthase inhibition attenuates L-DOPA-induced dyskinesias in a rodent model of Parkinson's disease.
Topics: Animals; Antiparkinson Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; En | 2009 |
Lack of tolerance for the anti-dyskinetic effects of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in rats.
Topics: Animals; Anti-Dyskinesia Agents; Corpus Striatum; Disease Models, Animal; Dyskinesia, Drug-Induced; | 2010 |
Neuronal nitric oxide synthase inhibition attenuates the development of L-DOPA-induced dyskinesia in hemi-Parkinsonian rats.
Topics: Animals; Anti-Dyskinesia Agents; Antiparkinson Agents; Dopamine and cAMP-Regulated Phosphoprotein 32 | 2012 |
Nitric oxide synthase inhibitors cause motor deficits in mice.
Topics: Animals; Brain Chemistry; Catalepsy; Dopamine; Dopamine Antagonists; Dyskinesia, Drug-Induced; Enzym | 2001 |